Referenzen
Produkte Transfektion
Kostenlose Testsamples
Anwendungshinweise:
Im „Transfection Reagent Selection Guide“ können Sie durch Filterfunktionen z.B. für Ihre Kombination aus zu transfizierender Zelle und Nukleinsäure die Liste vorhandener Referenzen durchsuchen. Ebenso können Sie im Feld „Referenzen durchsuchen“ am Anfang der Seite mit passenden Schlagwörtern zu einem Ergebnis gelangen. Eine Referenz zeigt an, dass das gefundene Transfektionsreagenz bereits erfolgreich für die entsprechende Anwendung verwendet wurde. Im Idealfall sind getestete Transfektionsparameter und Transfektionseffizienzen angegeben.
Keine Referenz? > Allgemeine Auswahlhilfe
Wenn Sie keine Referenz gefunden haben, heißt das nicht, dass kein passendes Reagenz zur Verfügung steht, sondern lediglich, dass bisher keine Erfahrungsberichte vorliegen. In diesem Falle kann durch eine Vorauswahl ein erfolgsversprechendes Transfektionsreagenz ausgewählt (Allgemeine Auswahlhilfe) und letztendlich ausgetestet (Kostenlose Testsamples) werden. Wenn Sie einen Erfahrungsbericht für uns schreiben möchten machen wir Ihnen ein Angebot für eine Gegenleistung.
CELL TYPE | DESCRIPTION OF CELL TYPE | CAT.NO. | SPECIES | ORIGIN OF CELLS | COMMON CELL TYPE | GROWTH PROPERTIES | NUCLEIC ACID / DELIVERED MOLECULE | APPLICATION | PRODUCT | REFERENCE TYPE | BIBLIOGRAPHIC DATA | LINK | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
LNCaP |
Human prostate carcinoma cell line | ATCC CRL-1740 | Human | genital tract | cell line | adherent | plasmid | RNA-Interference | Metafectene | publication | U. K. Mukhopadhyay et al., Cancer Res., Apr 2005; 65: 2872 - 2881 | Link | |
LNCaP |
prostate epithelial cancer cells | ATCC CRL-1740 | Human | genital tract | cell line | adherent | plasmid | Metafectene | publication | M. Ansems et al., The Prostate, 2012, 72: 1708-1717, DOI 10.1002/pros.22522 | |||
LNcaP |
Human prostate carcinoma cell line | ATCC CRL-1740 | Human | genital tract | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene | publication | G. Loubeau et al., PLoS ONE, 2014, 9(5): e96293, doi:10.1371/journal.pone.0096293 | Link | |
LNCaP |
Human prostate carcinoma cell line | ATCC CRL-1740 | Human | genital tract | cell line | adherent | plasmid | Metafectene | publication | U. K. Mukhopadhyay et al., Cytokine, 2016; 82: 70-79; doi.org/10.1016/j.cyto.2016.01.013 | |||
LNCaP |
Human prostate carcinoma cell line | ATCC CRL-1740 | Human | genital tract | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | K. S. R. Sastry et al., J. Biol. Chem., Jul 2006; 281: 20891 - 20901 | Link | |
LoVo |
Human colon adenocarcinoma cell line | ATCC CCL-229 | Human | digestive organs | cell line | adherent | plasmid | cotransfection (plasmid/siRNA) | Metafectene | publication | L. M. Williams, Dissertation, 2014, Royal College of Surgeons in Ireland | Link | |
LoVo |
Human colon adenocarcinoma cell line | ATCC CCL-229 | Human | digestive organs | cell line | adherent | plasmid | Metafectene | application note | ![]() |
|||
LoVo |
Human colon adenocarcinoma cell line | ATCC CCL-229 | Human | digestive organs | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene | publication | L. M. Williams, Dissertation, 2014, Royal College of Surgeons in Ireland | Link | |
LoVo |
Human colon adenocarcinoma cell line | ATCC CCL-229 | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | Z. Timsah et al., Nature Struct. & Mol. Biol., 2014, 21(2), doi:10.1038/nsmb.2752 | ||
LoVo |
Human colon adenocarcinoma cell line | ATCC CCL-229 | Human | digestive organs | cell line | adherent | siRNA | cotransfection (plasmid/siRNA) | Metafectene | publication | L. M. Williams, Dissertation, 2014, Royal College of Surgeons in Ireland | Link | |
LoVo |
Human colon adenocarcinoma cell line | ATCC CCL-229 | Human | digestive organs | cell line | adherent | plasmid | RNA-Interference | Metafectene | publication | L. M. Williams, Dissertation, 2014, Royal College of Surgeons in Ireland | Link | |
LoVo |
Human colon adenocarcinoma cell line | ATCC CCL-229 | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | L. M. Williams, Dissertation, 2014, Royal College of Surgeons in Ireland | Link | |
LOX |
Human amelanotic melanoma cell line | Human | skin | cell line | plasmid | Metafectene | publication | S. E. Tague et al., PNAS, Jun 2004; 101: 9671 - 9676 | Link | ||||
LOX |
Human amelanotic melanoma cell line | Human | skin | cell line | plasmid | Metafectene | publication | A. H. Grossmann et al., Sci. Signal., Mar 2013; 6: ra14 | |||||
LS174T |
Human colon adenocarcinoma cell line | ATCC CL-188 | Human | digestive organs | cell line | adherent | plasmid | Metafectene | application note | ![]() |
|||
Ma-Mel-2 |
Malignant melanoma cell line | Human | skin | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | A. Vamanet al., 2015, PLoS ONE 10(6): e0129219; doi:10.1371/journal.pone.0129219 | Link | ||
Ma-Mel-86a |
Malignant melanoma cell line | Human | skin | cell line | adherent | plasmid | stable transfection | Metafectene | publication | S. Löffek et al., Front. Oncol., 2015, 5:234; doi: 10.3389/fonc.2015.00234 | Link | ||
Ma-Mel-86a |
Malignant melanoma cell line | Human | skin | cell line | plasmid | stable transfection | Metafectene | publication | N. Ullrich et al., Cancer Res., May 2015; 75: 1897 - 1907 | Link | |||
MC3T3-E1 |
Mouse osteoblast cell line | ATCC CRL-2593 | Mouse | bone | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | C.-L. Tsai et al., Bone, 2014, 60 :186-197, doi.org/10.1016/j.bone.2013.12.014 | ||
MC3T3-E1 |
Mouse osteoblast cell line | ATCC CRL-2593 | Mouse | bone | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | C.-L. Tsai et al., Journal of Biomedical Science, 2014, 21:12, doi:10.1186/1423-0127-21-12 | Link | |
MC3T3-E1 |
Mouse osteoblast cell line | ATCC CRL-2593 | Mouse | bone | cell line | adherent | plasmid | Metafectene | publication | H.-J. Kim et al., Scientific Reports, Feb. 2017, 7: 42882, DOI: 10.1038/srep42882 | Link | ||
MC3T3-E1 |
Mouse osteoblast cell line | ATCC CRL-2593 | Mouse | bone | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | Y.-y. Li et al., FASEB, 2012 | ||
MC3T3-E1 |
Mouse osteoblast cell line | ATCC CRL-2593 | Mouse | bone | cell line | adherent | plasmid | Metafectene | publication | C.-L. Tsai et al., Journal of Biomedical Science, 2014, 21:12, doi:10.1186/1423-0127-21-12 | Link | ||
MCF-7 |
Human breast adenocarcinoma cell line | ATCC HTB-22 | Human | breast | cell line | adherent | plasmid | stable transfection | Metafectene | publication | M. Ansems et al., Breast Cancer Res. Treat., 2015, 149:693–703; DOI: 10.1007/s10549-015-3281-y | Link | |
MCF-7 |
Human breast adenocarcinoma cell line | ATCC HTB-22 | Human | breast | cell line | adherent | plasmid | Metafectene | publication | Y. V. Kuznetsov et al., Steroids, 2018, doi.org/10.1016/j.steroids.2018.07.007 |